Publication: Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus
Issued Date
2018-11-12
Resource Type
ISSN
16643224
Other identifier(s)
2-s2.0-85056590901
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Frontiers in Immunology. Vol.9, No.NOV (2018)
Suggested Citation
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M.N. Iqbal, Wanpen Chaicumpa Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus. Frontiers in Immunology. Vol.9, No.NOV (2018). doi:10.3389/fimmu.2018.02478 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/45945
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus
Other Contributor(s)
Lala Lajpat Rai University of Veterinary and Animal Sciences
Razi Vaccine & Serum Research Institute, Iran
Indian Council of Medical Research
Tamilnadu Veterinary Animal Sciences University
Barkatullah University
College of Veterinary Science India
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tecnologico de Monterrey
Indian Veterinary Research Institute
College of Veterinary Sciences and Animal Husbandry
Razi Vaccine & Serum Research Institute, Iran
Indian Council of Medical Research
Tamilnadu Veterinary Animal Sciences University
Barkatullah University
College of Veterinary Science India
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tecnologico de Monterrey
Indian Veterinary Research Institute
College of Veterinary Sciences and Animal Husbandry
Abstract
© 2018 Dadar, Chakraborty, Dhama, Prasad, Khandia, Hassan, Munjal, Tiwari, Karthik, Kumar, Iqbal and Chaicumpa. Human papillomavirus (HPV) is a viral infection with skin-to-skin based transmission mode. HPV annually caused over 500,000 cancer cases including cervical, anogenital and oropharyngeal cancer among others. HPV vaccination has become a public-health concern, worldwide, to prevent the cases of HPV infections including precancerous lesions, cervical cancers, and genital warts especially in adolescent female and male population by launching national programs with international alliances. Currently, available prophylactic and therapeutic vaccines are expensive to be used in developing countries for vaccination programs. The recent progress in immunotherapy, biotechnology, recombinant DNA technology and molecular biology along with alternative and complementary medicinal systems have paved novel ways and valuable opportunities to design and develop effective prophylactic and therapeutic vaccines, drugs and treatment approach to counter HPV effectively. Exploration and more researches on such advances could result in the gradual reduction in the incidences of HPV cases across the world. The present review presents a current global scenario and futuristic prospects of the advanced prophylactic and therapeutic approaches against HPV along with recent patents coverage of the progress and advances in drugs, vaccines and therapeutic regimens to effectively combat HPV infections and its cancerous conditions.